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Higher cerebral functions are based upon a dynamic organization of neuronal networks. To form synaptic connections and to continuously re-
shape them in a process of ongoing structural adaptation, neurons must permanently withdraw from the cell cycle. In other words, synaptic
plasticity can only occur on the expense of the ability to proliferate. Previously, we have put forward a hypothesis, coined “Dr. Jekyll and Mr.
Hyde concept” that differentiated neurons after having withdrawn from the cell cycle are able to use those molecular mechanisms primarily
developed to control proliferation alternatively to control synaptic plasticity [T. Arendt, Synaptic plasticity and cell cycle activation in neurons are
alternative effector pathways The Dr. Jekyll and Mr. Hyde Theory of Alzheimer's disease or The yin and yang of Neuroplasticity. Progr.
Neurobiol. 71 (2003) 83–248]. The existence of these alternative effector pathways within a neuron might put it on the risk to erroneously convert
signals derived from plastic synaptic changes into cell cycle activation which subsequently leads to cell death. Here we add further evidence to this
hypothesis demonstrating a tight association of the origin recognition complex (ORC) with neurofibrillar pathology in AD. The ORC is a critical
“guard” of DNA replication and point of convergence of numerous functionally redundant signaling pathways involved in cell cycle progression
and transcriptional silencing of apoptotic programmes. ORC subunits in the mammalian brain and their homologes in Drosophila, however, have
further been implicated in the regulation of structural neuronal plasticity and cognitive function. We propose that the abnormal subcellular
distribution and segregation of ORC proteins in AD might compromise their physiological function in gene silencing and plasticity. This might
result in cell cycle activation, DNA-replication and de-repression of apoptotic programmes. ORC subunits might, thus, provide a direct molecular
link between synaptic plasticity, DNA replication and cell death.
© 2006 Elsevier B.V. All rights reserved.Keywords: Alzheimer's disease; Cell cycle; Cell death; Origin recognition complex; Plasticity; Synapse1. 100 years Alzheimer's disease – 10 years cell cycle
dysfunction in AD – what cell biology can teach us
Alzheimer's disease is not only the most frequent dementing
disorder of higher age. Ever since Emil Kraepelin [2] attributed
the name of his co-worker Alois Alzheimer to the disease fighting
non-biological approaches in psychiatry, research on this disease
paradigmatically mirrors theoretical and practical approaches to
understand the cerebral basis of mental dysfunction as a special
aspect of the brain-behaviour-relationship which to a large extent
is driven by the technical state-of-art of brain research.
Early work on the diseased human brain at the beginning of
the 20th century as dominated bymorphological approaches was⁎ Corresponding author. Tel.: +49 341 9725721; fax: +49 341 9725729.
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doi:10.1016/j.bbadis.2006.12.005facilitated through new staining techniques. The development of
elective silver stains for axon cylinders and neuronal fibrils by
Max Bielschowsky and others coincidentally also led to the
discovery of the typical neurofibrillary changes described by
Bielschowsky and Brodmann [3], Alzheimer [4] and Fischer [5]
and to a more detailed investigation of senile plaques originally
described by Blocq and Marinesco [6].
After some prominence of psychoanalytical and holistic
approaches at the time after World War I, biological psychiatry
gained new ground on the basis of insights into chemical
synaptology [7]. Facilitated by psychopharmacological achieve-
ments in the middle of the century, defined psychopathological
syndromes were attributed to specific chemical neurotransmis-
sion systems. Dysfunction of dopaminergic synapses was
discovered as a cause of extrapyramidal symptoms [8],
noradrenergic and serotonergic systems were conceptually
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cognitive functions. A milestone was the identification of a
cholinergic dysfunction as a critical event in the pathogenesis of
cognitive dysfunction in AD in the late 1970s [9–11].
Ten years later, in the middle of the 1980s, new analytical
molecular biological tools became available promoting the
isolation and molecular characterization of pathological deposi-
tions in the brain of AD patients, now entirely shifting the
attention to the molecular level [12–17].
More recent developments intend to understand brain
function both under normal and disease-conditions on the
basis of specific cellular programmes. One of those programmes
where neurons differ from the rest of the cells are differentiation
and plasticity. A new concept, emerging about 10 years ago,
attributes neuronal death under conditions of neurodegenerative
disorders to a dysregulation of differentiation control leading to
cell-cycle re-entry and subsequently to cell death [18–24]. Our
understanding of Alzheimer's disease will develop as we gain
insight into the cell biological mechanisms that regulate
neuronal differentiation and plasticity. Here, we summarize
recent evidence on molecular links between synaptic plasticity
and cell cycle regulation.
2. Synapse loss is an early event in AD
Synapse loss is an early event in AD and the best correlate of
cognitive dysfunction [25–28]. Quantitative ultrastructural
studies performed on cortical biopsies within 2 to 4 years
after the clinical onset of the disease, revealed a 25% to 35%
decrease in the numerical density of synapses and a 15% to 35%
loss in the number of synapses per neuron [29]. Disturbances of
synaptic integrity can be detected already in MCI patients or
very mild AD cases [25]. Observations on biphasic changes of
distinct synaptic proteins [30] and the increase in synaptic size
accompanying synapse loss [28,27,31] make a failure of local
neuronal regulatory mechanisms of synaptic plasticity and
turnover very likely. This assumption is supported by findings
on a deregulation of proteins involved in structural plasticity of
axons and dendrites [32–36], alterations in the composition
[37–40] and fluidity of membranes [41,42] as well as by direct
morphological evidence of a disturbed axonal and dendritic
remodelling (for review see Arendt [1]).
3. Synaptic disconnection is associated with PHF-like
phosphorylation of tau in a model of structural synaptic
plasticity
As shown recently, synaptic disconnection under condi-
tions of hypometabolism in hibernation is associated with
PHF-like phosphorylation of tau in target neurons [43].
Hypometabolism induced by starvation or hypothermia
similarly induces hyperphosphorylation of tau [44,45].
Depression of the metabolic state of neurons during torpor
in hibernating mammals leads to a greatly reduced electro-
encephalographic activity [46–48]. As activity is a measure
of use, and neuronal connections remain functional through
regular use, this decrease negatively affects the maintenanceof neuronal connections [49]. The hibernation cycle, thus
represent a physiological model which allows to study
sequelae of reduced neuronal connectivity. Synaptic regres-
sion during torpor and subsequent reinnervation in phases of
arousal has been particularly well characterized for mossy
fibers terminating on CA3 hippocampal pyramidal neurons
[43,50–52]. Stages of synaptic disconnection are associated
with the formation of PHF-like phosphorylated tau in CA3
pyramidal cells which loose their afferentation through the
mossy fibers (Fig. 1). This PHF-like tau phosphorylation is
quickly and fully reversible during arousal when mossy
fibers re-connect to pyramidal neurons. These findings
implicate a critical link between synaptic plasticity and
PHF-like phosphorylation of tau, an essential element of AD
pathology.
4. Synaptic plasticity and cell cycle activation in neurons
are alternative effector pathways
To form synaptic connections and to continuously re-shape
them in a process of ongoing structural adaptation, neurons
must permanently withdraw from the cell cycle. In other words,
synaptic plasticity can only occur on the expense of the ability
to proliferate. Previously, we have put forward a hypothesis,
called the “Dr. Jekyll and Mr. Hyde concept” that differentiated
neurons after having withdrawn from the cell cycle are able to
use those molecular mechanisms primarily developed to control
proliferation alternatively to control synaptic plasticity [1] (Fig.
2). The existence of these alternative effector pathways within a
neuron might put it on the risk to erroneously convert signals
derived from plastic synaptic changes into the ancient
programme of cell cycle activation which subsequently leads
to cell death. Cell cycle activation might, thus, link synaptic
plasticity to cell death [1].
Up-regulation of a variety of molecules critically involved in
activation and progression of the cell cycle, indicating a cell
cycle re-entry of neurons, occurs at early phases of neurode-
generation in AD [21,23,24]. This cell-cycle re-activation most
likely is a down-stream effect of activated mitogenic signaling
[18,19,53]. As we showed recently, the p21ras-MAP-kinase-
pathway, a mitogenic pathway that in cycling cells controls
proliferation, regulates neuronal plasticity of differentiated
neurons (Fig. 3). These observations provide direct evidence
that depending on the cellular context, cell cycle activation and
plasticity might involve identical molecular pathways. In AD,
these pathways are upregulated very early during the course of
the disease and prior to any other noticeable sign of pathology
[18,19,53].
5. Cell cycle regulators might serve non-canonical
functions in differentiated neurons
Recent studies indicate that, contrary to classical beliefs,
molecules known to be involved in activation and progression
of the cell cycle are not entirely repressed in differentiated
neurons where they might subserve alternative “non-canonical
functions” such as regulation of plasticity [54].
Fig. 1. Cyclic changes in the hippocampal mossy fibre system during hibernation. Top: mossy fibres labelled by PSA-NCAM. Note the disappearance of staining
during torpor and its progressive reappearance during arousal: Middle: pre- and postsynaptic changes of mossy fibre synapses at apical dendrites of CA pyramidal
neurons in the stratum lucidum. Immunohistochemical reaction for synaptophysin decreases and increases again with a similar time course as the PSA-NCAM labeling
of mossy fibres. MAP-2 (green) reactivity in the stratum lucidum disappears in torpor and re-appears during arousal with a similar time course as PSA-NCAM and
synaptophysin. An inverse pattern is observed for AT8 reactivity (red, co-expression with MAP-2 in yellow) in corresponding pyramidal cell bodies. Bottom:
Schematic representation of cyclic synaptic disconnection of mossy fibres terminating on CA pyramidal neurons and its association with formation of PHF-like
phosphorylated tau (red) in target neurons. (Modified after Arendt [43]).
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convergence of numerous functionally redundant signaling
pathways involved in cell cycle progression is represented by
the origin recognition complex (ORC). The ORC controls
initiation of DNA replication, prevents re-replication during the
cell cycle and is also involved in morphogenetic processes [55].
The mammalian ORC is composed of six distinct subunits [56],
numbered according to increasing migration as judged by SDS-
PAGE (Orc1 to Orc6). Orc2 to Orc6 appear to remain chromatin
bound at all stages in mammalian cells, and only Orc1
expression correlates with the level of tissue proliferation
[57,58]. In contrast, mRNA levels of the other ORC subunits
(Orc2–5) do not depend on the proliferative activity of thetissue. The ORC core units Orc2–5 are also expressed in brains
of human [58] and mice [55], where they are enriched in the
membrane fraction indicating a function beyond controlling
DNA replication.
6. Abnormal subcellular distribution/segregation of the
origin recognition complex in AD
ORC units playing a critical role both in DNA replication
and synaptic plasticity are also involved in AD pathology [59].
In proliferating HeLa and SH-SY5Y neuroblastoma cells,
ORC subunits are typically found at mitotic plates. In AD,
ORC units show pathological alterations of their subcellular
Fig. 2. Synopsis of major principles underlaying the proposed “Dr. Jekyll and Mr. Hyde concept” [1] relating neurodegeneration to a phylogenetically regressive
response potentially inherent to neurons. Non-neuronal cells (e.g. fibroblasts) typically sense their relationship to local neighboring cells to control proliferation and
survival which guarantees tissue integrity through repair and cellular replacement. Neurons need to sense their relationship to neighboring neurons to serve the
phylogenetically newly acquired function of information processing in a network. This network requires dynamic rather than static intercellular connections and
connectivity is permanently altered. As a consequence, neurons need to withdraw from the cell cycle. If within this framework connectivity is altered due to some
requirement in the informational network, a risk of “misinterpretation” and, thus, phylogenetic regression is inherent, with the consequence of activation of an
“ancient” mechanisms for cellular repair and replacement that involves cell cycle activation. This induction of a proliferation response against the mature background
of the nervous system eventually results in the death of the neuron.
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Fig. 3. Effects of permanently activated p21ras-MAP-kinase pathway on structural neuronal plasticity in vivo. A synRas mouse model was used expressing
constitutively activated Ha-Ras (Val12 mutation) in neurons under control of the synapsin promotor to investigate the role of Ras-MAP-kinase signaling for neuronal
plasticity in the adult brain. Top: effects on the size and ramification of dendritic arborisation of pyramidal neurons in the somatosensory cortex. (Two-dimensional
projected confocal images of Lucifer Yellow filled layer V pyramidal cells.). Middle: effects on number and distribution of dendritic spines of layer V pyramidal
neurons in the somatosensory cortex. (Rendered confocal images of spine-bearing dendrites). Bottom: effects on the number and size of synaptic contacts in the
somatosensory cortex. (Synaptic contacts in layer II/III, ultrathin sections; reacted with ethanolic phosphotungstic acid). (Modified after Arendt [75]).
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with neurofibrillar tau pathology in form of neurofibrillary
tangles, neuropil threads and plaque-associated dystrophic
neurites indicating their pathological segregation (Fig. 4).
7. ORC's function beyond DNA replication: linking
synaptic plasticity to cell cycle
The clearest case for an alternate function for ORC beyond
DNA replication is in transcriptional gene silencing and
heterochromatin formation [60–64]. Genetic studies in budding
yeast demonstrated that mutants of ORC genes could be
identified that distinguished between ORC's function in DNA
replication and its role in transcriptional silencing [65–67]. The
majority of genes repressed in a ORC-dependent manner are
genes induced by starvation or other aspects of a deleterious
environment and involve effects associated with DNA damageand an induction of an apoptotic programme [68,69]. Dereg-
ulation of ORC-dependent gene silencing in budding yeast has
been suggested to contribute to replicative aging and an
apoptotic phenotype of aged cells [69,70]. Large scale
repression of genes by ORC may be related to effects of their
gene products that are incompatible with cell cycling. It might
be reasonable to propose a similar role for ORC in higher
eukaryotes, where ORC has also been shown to interact with
proteins required for heterochromatin formation.
Several ORC subunits associate with several still unidenti-
fied cellular proteins with a higher affinity than with known
ORC subunits [58]. Proteins not involved in DNA replication
might recruit ORC subunits to functions other than initiation of
DNA replication. For example the Drosophila Orc3 homologue
Latheo has been implicated in learning [71–73]. Flies with a
hypomorphic mutation in Latheo have a smaller than normal
mushroom body and defects in synaptic transmission and
Fig. 5. Proposed model for the involvement of ORC elements in regulating synaptic plasticity, DNA replication and transcription. The modification of synaptic
connectivity which involves the formation and stabilisation of new synapses simultaneously with the degradation of other synapses requires a selective targeting of
synapses (see also Fig. 3). According to the model of Featherstone and Broadie [74], this requirement can be fulfilled by ORC elements. In response to some trans-
synaptic signal under normal conditions, ORC elements translocate from the synapse to the nucleus where they direct new programmes of gene transcription important
for synaptic modulation (synaptic strengthening, synaptic degradation) while apoptotic programmes are silenced (top). Sequestration to fibrillar pathology in AD
prevents ORC elements from their physiological function of gene transcription/silencing. As a consequence, apoptotic programmes are de-repressed, and DNA
replication is promoted (bottom).
Fig. 4. Association of ORC3with neurofibrillar pathology in AD. Double-immunohistochemical labeling for ORC3 (abcam ab9213, red, Cy3) and PHF-tau (mAbAT8,
Perbio Science MN1020, green, Cy2). Superimposed images (right) show co-localisation in yellow (arrows).
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explained by a role of Orc3 in cell proliferation, defects in
synaptic transmission have implicated Orc3 in a synaptic
function. Latheo is present in the cytoplasm of postmitotic
neurons, and is also abundant in boutons of presynaptic
terminals at the Drosophila neuromuscular junction, far from
any nuclei [73]. It regulates both evoked transmission amplitude
and activity-dependent forms of synaptic facilitation and
potentiation [73]. These results show that Latheo plays two
neuronal roles: a nuclear role in DNA replication/transcription,
and a role in synaptic plasticity. It has, thus been suggested a
model where Latheo serves an information shuttle between the
nerve terminal and the nucleus participating in synapse-to-
nucleus signaling [74]. In this model, Latheo would thus
directly link the synaptic terminal with gene regulation.
More recently, a similar role was shown for ORC subunits in
the mammalian brain. ORC3 and ORC5 loss of function
phenotypes in hippocampal pyramidal neurons induced by
siRNA in mice neuronal cultures revealed a regulation on
dendrite and spine development [55]. These data directly
support our hypothesis that neurons have evolutionary acquired
the ability to use molecular mechanisms primarily developed to
control proliferation alternatively to control synaptic plasticity
[1]. As outlined previously [1], the existence of these alternative
effector pathways within a neuron, puts it permanently on the
risk to erroneously convert signals derived from plastic synaptic
changes into positional cues that will activate the cell cycle.
Moreover, molecules with dual functions, such as ORC
elements, involved in regulation both at synaptic sites and
DNA show an aberrant subcellular distribution and association
to PHF-tau in AD. This abnormal compartmentation might
segregate these regulatory elements from their physiological
function in regulating plasticity and gene silencing and will,
thus, result in a de-repression of genes triggering an apoptotic
phenotype (Fig. 5).
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